CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it will be presenting at the Sixth Annual Needham & Company Biotechnology and Medical Technology Conference on June 13, 2007 at 9:30 a.m. EDT in New York.
